HINGHAM, Mass., Jan. 08, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: MBOT) today announced that it has entered into definitive agreements for the purchase and sale of 3,788,550 shares of the Company’s common ...
Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius Pharma" or the "Company"), a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, ...
The research team at J.P. Morgan is out with the firm's 2025 Year Ahead Best Idea list, and we found five companies that look ...
As the healthcare real estate market flourishes, fueled by demographic transformations and cutting-edge advancements in ...
With the UK snow storm continuing to batter the country, drivers and motorists are being urged to use a household staple to ...